IBTROZI
Nuvation Bio Scores First FDA Approval for Oral Lung Cancer Drug Ibtrozi
Nuvation Bio; FDA approval; Ibtrozi; taletrectinib; lung cancer; ROS1-positive NSCLC; oral treatment; tyrosine kinase inhibitor
Actionable Insights Powered by AI
Nuvation Bio; FDA approval; Ibtrozi; taletrectinib; lung cancer; ROS1-positive NSCLC; oral treatment; tyrosine kinase inhibitor